Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

DRTECH Corporation (214680.KQ)

Compare
1,851.00
+32.00
+(1.76%)
At close: April 4 at 3:30:02 PM GMT+9
Loading Chart for 214680.KQ
  • Previous Close 1,819.00
  • Open 1,780.00
  • Bid 1,835.00 x --
  • Ask 1,850.00 x --
  • Day's Range 1,773.00 - 1,860.00
  • 52 Week Range 1,701.00 - 4,885.00
  • Volume 617,973
  • Avg. Volume 1,308,112
  • Market Cap (intraday) 136.469B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, and AI CAD; and radiography, mammography, and C-arm systems. DRTECH Corporation was founded in 2000 and is headquartered in Seongnam-si, South Korea.

www.drtech.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 214680.KQ

View More

Performance Overview: 214680.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

214680.KQ
18.82%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

214680.KQ
40.58%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

214680.KQ
12.52%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

214680.KQ
40.23%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 214680.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 214680.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    136.47B

  • Enterprise Value

    193.95B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.40

  • Price/Book (mrq)

    1.89

  • Enterprise Value/Revenue

    1.99

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.77%

  • Return on Assets (ttm)

    -4.41%

  • Return on Equity (ttm)

    -24.51%

  • Revenue (ttm)

    97.56B

  • Net Income Avi to Common (ttm)

    -19.29B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.91B

  • Total Debt/Equity (mrq)

    106.99%

  • Levered Free Cash Flow (ttm)

    -18.17B

Research Analysis: 214680.KQ

View More

Company Insights: 214680.KQ

Research Reports: 214680.KQ

View More

People Also Watch